Yadav Vikas, Singh Tejveer, Sharma Deepika, Garg Vivek Kumar, Chakraborty Payel, Ghatak Souvik, Satapathy Shakti Ranjan
Department of Translational Medicine, Clinical Research Centre, Lund University, 221 00 Malmö, Sweden.
Translational Oncology Laboratory, Department of Zoology, Hansraj College, University of Delhi, New Delhi 110021, India.
Cancers (Basel). 2024 Sep 18;16(18):3183. doi: 10.3390/cancers16183183.
Colorectal cancer (CRC) remains a significant global health burden with high incidence and mortality. MicroRNAs (miRNAs) are small non-protein coding transcripts, conserved throughout evolution, with an important role in CRC tumorigenesis, and are either upregulated or downregulated in various cancers. RNA-binding proteins (RBPs) are known as essential regulators of miRNA activity. Human antigen R (HuR) is a prominent RBP known to drive tumorigenesis with a pivotal role in CRC. In this review, we discuss the regulatory role of the HuR/miRNA axis in CRC. Interestingly, miRNAs can directly target HuR, altering its expression and activity. However, HuR can also stabilize or degrade miRNAs, forming complex feedback loops that either activate or block CRC-associated signaling pathways. Dysregulation of the HuR/miRNA axis contributes to CRC initiation and progression. Additionally, HuR-miRNA regulation by other small non-coding RNAs, circular RNA (circRNAs), or long-non-coding RNAs (lncRNAs) is also explored here. Understanding this HuR-miRNA interplay could reveal novel biomarkers with better diagnostic or prognostic accuracy.
结直肠癌(CRC)仍然是一个重大的全球健康负担,其发病率和死亡率都很高。微小RNA(miRNA)是小的非蛋白质编码转录本,在整个进化过程中保守,在CRC肿瘤发生中起重要作用,并且在各种癌症中要么上调要么下调。RNA结合蛋白(RBP)是已知的miRNA活性的重要调节因子。人类抗原R(HuR)是一种著名的RBP,已知在CRC中起关键作用驱动肿瘤发生。在这篇综述中,我们讨论了HuR/miRNA轴在CRC中的调节作用。有趣的是,miRNA可以直接靶向HuR,改变其表达和活性。然而,HuR也可以稳定或降解miRNA,形成复杂的反馈环,激活或阻断与CRC相关的信号通路。HuR/miRNA轴的失调有助于CRC的起始和进展。此外,本文还探讨了其他小非编码RNA、环状RNA(circRNA)或长链非编码RNA(lncRNA)对HuR-miRNA的调控。了解这种HuR-miRNA相互作用可能会揭示具有更好诊断或预后准确性的新型生物标志物。